Live Market Updates
Latest Financial News
News Feed
1 articles
Personalized
Live Market Updates
Latest Financial News
neutral
6 days agoInvestors eye Q2 results from Dr. Reddy’s, SBI Life, and SBI Cards
Investors awaited second-quarter earnings from Dr. Reddy’s Laboratories, SBI Life Insurance, and SBI Cards scheduled for release later today. Analysts forecast a 7–10% year-on-year revenue increase for Dr. Reddy’s, driven by strong North American generics performance. SBI Cards’ profit is expected to rise 18% sequentially to ₹606 crore on higher spending volumes, while SBI Life could post steady premium growth. The results will influence near-term sectoral sentiment and guide index positioning ahead of next week’s monthly derivatives expiry.
neutral
6 days agoInvestors eye Q2 results from Dr. Reddy’s, SBI Life, and SBI Cards
Investors awaited second-quarter earnings from Dr. Reddy’s Laboratories, SBI Life Insurance, and SBI Cards scheduled for release later today. Analysts forecast a 7–10% year-on-year revenue increase for Dr. Reddy’s, driven by strong North American generics performance. SBI Cards’ profit is expected to rise 18% sequentially to ₹606 crore on higher spending volumes, while SBI Life could post steady premium growth. The results will influence near-term sectoral sentiment and guide index positioning ahead of next week’s monthly derivatives expiry.
neutral
Investors eye Q2 results from Dr. Reddy’s, SBI Life, and SBI Cards
7 days ago
1 min read
78 words
Dr. Reddy’s, SBI Life, and SBI Cards Q2 results due today; analysts expect robust margins and double-digit growth across verticals.
Investors awaited second-quarter earnings from Dr. Reddy’s Laboratories, SBI Life Insurance, and SBI Cards scheduled for release later today. Analysts forecast a 7–10% year-on-year revenue increase for Dr. Reddy’s, driven by strong North American generics performance. SBI Cards’ profit is expected to rise 18% sequentially to ₹606 crore on higher spending volumes, while SBI Life could post steady premium growth. The results will influence near-term sectoral sentiment and guide index positioning ahead of next week’s monthly derivatives expiry.
Investors awaited second-quarter earnings from Dr. Reddy’s Laboratories, SBI Life Insurance, and SBI Cards scheduled for release later today. Analysts forecast a 7–10% year-on-year revenue increase for Dr. Reddy’s, driven by strong North American generics performance. SBI Cards’ profit is expected to rise 18% sequentially to ₹606 crore on higher spending volumes, while SBI Life could post steady premium growth. The results will influence near-term sectoral sentiment and guide index positioning ahead of next week’s monthly derivatives expiry.
Companies:
Dr. Reddy’s Laboratories
SBI Life
SBI Cards
Tags:
stocks
earnings
stocks
earnings
Dr. Reddy’s
SBI Life
SBI Cards
Oct 24, 2025 • 05:39 IST